Exact Mass: 469.1113264
Exact Mass Matches: 469.1113264
Found 148 metabolites which its exact mass value is equals to given mass value 469.1113264,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Indol-3-ylacetyl-myo-inositol L-arabinoside
C21H27NO11 (469.15840320000007)
2-(a-Hydroxyethyl)thiamine diphosphate
2-Hydroxyethyl-ThPP is involved in Glycolysis, Gluconeogenesis, Alanine and aspartate matabolism, Valine, Leucine and isoleucine biosynthesis, Pyruvate metabolism, and Butanoate metabolism [Kegg: c05125] [HMDB] 2-Hydroxyethyl-ThPP is involved in Glycolysis, Gluconeogenesis, Alanine and aspartate matabolism, Valine, Leucine and isoleucine biosynthesis, Pyruvate metabolism, and Butanoate metabolism [Kegg: c05125].
RO4929097
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
O-Methyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate
C21H27NO9S (469.1406452000001)
O-Methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate is a fully acetylated thiocarbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers differ in the orientation of the NH group with respect to sulfur.
(beta-1-O-[N-(2-hydroxymethyl-3-chlorophenyl)anthraniloyl]-D-glucupyranuronic acid)
C20H20ClNO10 (469.07756900000004)
(beta-1-O-[N-(2-hydroxymethyl-3-chlorophenyl)anthraniloyl]-D-glucupyranuronic acid) belongs to the family of Glucuronides. These are compounds comprising the glucuronic acid linked to another substance via a glycosidic bond.
Bucladesine
Oxaprozin glucuronide
RO4929097
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators
Thalictrine Iodide
(+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2]. (+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2].
5-O-beta-D-Glucopyranosyldihydroascorbigen
C21H27NO11 (469.15840320000007)
2-[1-[4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]indol-3-yl]acetic acid
C21H27NO11 (469.15840320000007)
8-Trichloromethyl-7,8-dihydropalmatine
C22H22Cl3NO4 (469.06143420000006)
O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (E)|O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (Z)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (E)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (Z)
C21H27NO9S (469.1406452000001)
N12-5(S)-N13-1(R)-L-rhamnosylarcyriaflavin
C26H19N3O6 (469.12737940000005)
5-O-beta-D-glucopyranosyl-dihydroABG|5-O-beta-D-glucopyranosyl-dihydroascorbigen
C21H27NO11 (469.15840320000007)
narciclasine-4-O-beta-D-glucopyranoside
C20H23NO12 (469.12201980000003)
CAY10576
C22H19N3O5S2 (469.07660840000005)
Bucladesine
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
CAY10589
C25H28ClN3O2S (469.15906580000006)
(indol-3-yl)acetyl-myo-inositol L-arabinoside
C21H27NO11 (469.15840320000007)
Thalictrine Iodide
(+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2]. (+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2].
Cys Cys Met Asn
Cys Cys Asn Met
Cys Met Cys Asn
Cys Met Asn Cys
Cys Asn Cys Met
Cys Asn Met Cys
N1-Demethylnicergoline
Met Cys Cys Asn
Met Cys Asn Cys
Met Asn Cys Cys
Asn Cys Cys Met
Asn Cys Met Cys
Asn Met Cys Cys
3-(2-BROMO-2-ETHOXYCARBONYL-VINYL)-2-PHENYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C24H24BrNO4 (469.08886040000004)
6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium methyl sulphate
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methyl 4-chlorobenzenesulfonate
C20H18ClF2N3O4S (469.0674562000001)
1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium acetate
C23H24ClN5O4 (469.15167340000005)
b-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate
C20H23NO12 (469.12201980000003)
fmoc-(s)-3-amino-4-(2-trifluoromethyl-phenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
Fmoc-(S)-3-Amino-4-(4-trifluoromethylphenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
Fmoc-(R)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Fmoc-(R)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
Fmoc-(R)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
Fmoc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Fmoc-(S)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
(6R)-3,8-dioxo-7t-(2-phenyl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]octane-2ξ-carboxylic acid 4-nitro-benzyl ester
C22H19N3O7S (469.09436640000007)
(4-METHYL-THIAZOL-2-YL)-PHENYL-AMINE
C20H23NO12 (469.12201980000003)
a-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate
C20H23NO12 (469.12201980000003)
4-nitrophenyl tetra-o-acetyl-beta-d-glucopyranoside
C20H23NO12 (469.12201980000003)
(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
C16H22F3N5O4S2 (469.10652480000005)
fmoc-(r)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Fmoc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid
C26H22F3NO4 (469.15008480000006)
Tris(ethylenediamine)rhodium(III) nitrate
C6H24N9O9Rh (469.07519440000004)
2-(2-phenyl-9H-carbazol-9-yl)dibenzo[b,d]thiophen-4-ylboronic acid
C30H20BNO2S (469.13077300000003)
fmoc-(s)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt
C24H24ClN3O5 (469.14044040000005)
Ki8751
C24H18F3N3O4 (469.12493440000003)
Voruciclib
C22H19ClF3NO5 (469.0903790000001)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
Sofpironium bromide
C22H32BrNO5 (469.14637220000003)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes[1].
CID 54733074
N-(1,3-benzodioxol-5-yl)-2-[[3-(2-methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]sulfanyl]acetamide
C22H19N3O5S2 (469.07660840000005)
3-fluoro-N-[4-[[4-(4-methoxyphenyl)-1-piperazinyl]-oxomethyl]phenyl]benzenesulfonamide
C24H24FN3O4S (469.14714760000004)
3-(4-{2-[2-(2-Bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid
(2s,4s,5r)-2-Isobutyl-5-(2-Thienyl)-1-[4-(Trifluoromethyl)benzoyl]pyrrolidine-2,4-Dicarboxylic Acid
C22H22F3NO5S (469.1170718000001)
(2R)-2-[(1R)-1-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Methyl 2-[3-methoxy-2-[(5-phenyl-1,2-oxazole-3-carbonyl)amino]phenyl]-1,3-benzoxazole-4-carboxylate
C26H19N3O6 (469.12737940000005)
2-[(4-{[([1,1-Biphenyl]-4-yl)methyl]amino}-6-chloropyrimidin-2-yl)sulfanyl]octanoic acid
C25H28ClN3O2S (469.15906580000006)
(2S)-2-[[[4-[(2-amino-4-oxo-3H-quinazolin-6-yl)methyl-formylamino]phenyl]-hydroxymethyl]amino]pentanedioic acid
6-[3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(indol-3-ylacetyl)-myo-inositol 3-L-arabinoside
C21H27NO11 (469.15840320000007)
[5-(4-Fluorophenyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-[2-(3-pyridinyl)-1-piperidinyl]methanone
1-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine
3-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoic acid (4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl) ester
C25H27NO6S (469.1559002000001)
[2-[2-(4-chlorophenyl)sulfanylanilino]-2-oxoethyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C24H20ClNO5S (469.0750660000001)
(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl) 4-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoate
C25H27NO6S (469.1559002000001)
[2-(2-Methylpropylcarbamoylamino)-2-oxoethyl] 3-[(3,4-difluorophenyl)sulfonylamino]benzoate
C20H21F2N3O6S (469.11190700000003)
N-(3-Methoxy-pyrazin-2-yl)-4-[3-(3-phenyl-acryloyl)-thioureido]-benzenesulfonamide
C21H19N5O4S2 (469.08784140000006)
3-{[4-(4-methoxyphenyl)piperazin-1-yl]carbonyl}benzimidazo[1,2-c]quinazoline-6(5H)-thione
7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid 2-methoxyethyl ester
C26H25ClFNO4 (469.14560520000003)
10-(2-Amino-ethylamino)-9-(3-chloro-phenyl)-2,2,5-trimethyl-1,4-dihydro-2H,9H-3-oxa-7-thia-6,9,11-tria za-benzo[c]fluoren-8-one
C23H24ClN5O2S (469.13391540000003)
N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide
C22H17F2N5O3S (469.1020116000001)
1-(3-Aminopropyl)-3-[3-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]propyl]thiourea
C19H25BrClN5S (469.07024600000005)
dihydroascorbigen 5-O-beta-D-glucoside
C21H27NO11 (469.15840320000007)
A dihydroascorbigen hexoside in which the hexoside component is a beta-D-glucosyl residue attached at position 5 via a glycosidic bond.
N-(2,6-dimethoxy-4-pyrimidinyl)-4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide
C21H19N5O4S2 (469.08784140000006)
butanoic acid [(4aS,5R,6R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
2-methoxyethyl (4S,7S)-7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C26H25ClFNO4 (469.14560520000003)
methyl (2S)-2-[[(2Z)-2-(3,5-dioxo-4-phenyloxolan-2-ylidene)-2-phenylacetyl]amino]-3-phenylpropanoate
[(4aR,5R,6R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphinin-5-yl] butanoate
butanoic acid [(4aS,6S,7S,7aS)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-(hydroxymethyl)-3-oxo-1-phenylpropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(3-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
(2S)-2-azaniumyl-5-{[(2R)-1-[(carboxylatomethyl)amino]-1-oxo-3-{[(2-phenylethyl)carbamothioyl]sulfanyl}propan-2-yl]amino}-5-oxopentanoate
oxolan-2-ylmethyl 4-(6-chloro-4-oxochromen-3-yl)-2-methyl-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxylate
C25H24ClNO6 (469.12920740000004)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(4-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2-methyl-3-oxo-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(2-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-3-oxo-1-phenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(4-methoxyphenyl)-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O8S (469.15187820000006)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate
C21H27NO11 (469.15840320000007)
(4-Methoxybenzyl)thiocarbamic acid 4-O-(tri-O-acetyl-alpha-L-rhamnopyranoside)
C21H27NO9S (469.1406452000001)
Inauhzin
Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.
(2s,3r,4s)-4-{[(2r,3s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)
(3s,4r,5s)-3,4-dihydroxy-5-[(1s)-2-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-3-(1h-indol-3-ylmethyl)oxolan-2-one
C21H27NO11 (469.15840320000007)
3,4,10,11-tetramethoxy-5-(trichloromethyl)-7,8-dihydro-5h-6-azatetraphene
C22H22Cl3NO4 (469.06143420000006)
10-Formylfolic acid
-
4,5-bis(acetyloxy)-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C21H27NO9S (469.1406452000001)
17-hydroxy-11-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione
(7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
17-hydroxy-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione
3,4-dihydroxy-5-(2-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-3-(1h-indol-3-ylmethyl)oxolan-2-one
C21H27NO11 (469.15840320000007)
(5s)-3,4,10,11-tetramethoxy-5-(trichloromethyl)-7,8-dihydro-5h-6-azatetraphene
C22H22Cl3NO4 (469.06143420000006)
(2s,3r,4s,4ar)-4-{[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)
(2r,3r,4s,4ar)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol
C20H23NO12 (469.12201980000003)
(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C21H27NO9S (469.1406452000001)
2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol
C20H23NO12 (469.12201980000003)
[(1e)-2-{2-[(3,4-dihydroxyphenyl)(hydroxy)methyl]-2h-1,3-benzodioxol-5-yl}ethenyl]oxysulfonic acid; dimethylguanidine
C19H23N3O9S (469.1154948000001)
4-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)
(2s)-2-[(4-{n-[(4-hydroxy-2-imino-1h-pteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioic acid
C20H19N7O7 (469.13459040000004)